StockData
Oragenics Inc logo

Oragenics Inc (OGEN) stock

OGENNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$0.19−0.02 (-10.00%)

Close on Nov 18, 2026Market cap $852.76KP/E –Yield –

Oragenics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Oragenics's free cash flow for the twelve months ending Dec 31, 2022 was -$15.36M. For fiscal 2022 it was -$15.36M. The highest annual figure on record is -$5.22M in fiscal 2012.

Annual free cash flow

PeriodPeriod endValueChange
FY2022Dec 31, 2022-$15.36M–
FY2021Dec 31, 2021-$13.51M–
FY2019Dec 31, 2019-$13.04M–
FY2018Dec 31, 2018-$9.20M–
FY2016Dec 31, 2016-$7.10M–
FY2015Dec 31, 2015-$5.29M–
FY2014Dec 31, 2014-$5.67M–
FY2013Dec 31, 2013-$6.78M–
FY2012Dec 31, 2012-$5.22M–
FY2010Dec 31, 2010-$6.54M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2022Dec 31, 2022-$2.44M–
Q3 FY2022Sep 30, 2022-$3.81M–
Q2 FY2022Jun 30, 2022-$3.38M–
Q1 FY2022Mar 31, 2022-$5.72M–
Q4 FY2021Dec 31, 2021-$2.50M–
Q4 FY2019Dec 31, 2019-$3.95M–
Q3 FY2019Sep 30, 2019-$3.38M–
Q4 FY2018Dec 31, 2018-$3.04M–
Q4 FY2016Dec 31, 2016-$1.96M–

More Oragenics figures

See a number that looks wrong?